 Connection
Martin McCarter to Lymph Node Excision
This is a "connection" page, showing publications Martin McCarter has written about Lymph Node Excision.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.768 |
|
|
|
-
Kounalakis N, Gao D, Gonzalez R, Becker M, Lewis K, Poust J, Pearlman N, Robinson W, McCarter M. A neoadjuvant biochemotherapy approach to stage III melanoma: analysis of surgical outcomes. Immunotherapy. 2012 Jul; 4(7):679-86.
Score: 0.353
-
Stewart CL, Gleisner A, Kwak J, Chapman B, Pearlman N, Gajdos C, McCarter M, Kounalakis N. Implications of Sentinel Lymph Node Drainage to Multiple Basins in Head and Neck Melanoma. Ann Surg Oncol. 2017 May; 24(5):1386-1391.
Score: 0.121
-
Merkow J, Paniccia A, Jones E, Jones T, Hodges M, Stovall R, Kounalakis N, Gajdos C, Lewis K, Robinson W, Gonzalez R, Pearlman N, McCarter M. Association of sentinel lymph node diameter with melanoma metastasis. Am J Surg. 2016 Aug; 212(2):315-20.
Score: 0.113
-
Leonard LD, Beaty L, Thomas M, Quinn C, Colborn KL, de Araujo TB, Torphy RJ, Assumpção LR, Olino K, Studts CR, Rodriguez Franco S, McCarter M, Stewart C, Gleisner AL. Unmeasured factors are associated with the use of completion lymph node dissection (CLND) in melanoma. J Surg Oncol. 2023 Mar; 127(4):716-726.
Score: 0.045
-
Torphy RJ, McCarter MD, Gleisner AL. ASO Author Reflections: Adjuvant Therapy for Stage III Melanoma With or Without Completion Lymph Node Dissection. Ann Surg Oncol. 2022 02; 29(2):816-817.
Score: 0.042
-
Torphy RJ, Friedman C, Ho F, Leonard LD, Thieu D, Lewis KD, Medina TM, Robinson WA, Gonzalez RC, Stewart CL, Kounalakis N, McCarter MD, Gleisner A. Adjuvant Therapy for Stage III Melanoma Without Immediate Completion Lymph Node Dissection. Ann Surg Oncol. 2022 Feb; 29(2):806-815.
Score: 0.042
-
Kwak JJ, Kesner AL, Gleisner A, Jensen A, Friedman C, McCarter MD, Koo PJ, Morgan RL, Kounalakis N. Utility of Quantitative SPECT/CT Lymphoscintigraphy in Guiding Sentinel Lymph Node Biopsy in Head and Neck Melanoma. Ann Surg Oncol. 2020 May; 27(5):1432-1438.
Score: 0.037
-
Lewis KD, Robinson WA, McCarter M, Pearlman N, O'Day SJ, Anderson C, Amatruda TT, Baron A, Zeng C, Becker M, Dollarhide S, Matijevich K, Gonzalez R. Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma. J Clin Oncol. 2006 Jul 01; 24(19):3157-63.
Score: 0.015
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|